Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06994442 · ClinicalTrials.gov registry record · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
A Phase 3 study of Mechanical Ventilation and Sedation and Analgesia, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 644
- Enrollment target
- 15
- Study locations
NCT06994442: Recruiting Phase 3 study of Mechanical Ventilation and Sedation and Analgesia, sponsored by Weill Medical College of Cornell University.
NCT06994442 is a Phase 3 study of Mechanical Ventilation and Sedation and Analgesia that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 644 participants, above the 551-participant average among 14 other Mechanical Ventilation trials with a reported enrollment target (17% higher). The trial reports 15 study locations across 11 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06994442, a Phase 3 study of Mechanical Ventilation and Sedation and Analgesia, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 644 participants
- Enrollment target
- 15
- Study locations
Study Summary
In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help with pain while they are on the ventilator, but investigators don't know if this is the best way to manage their pain. Even with strong doses of opioids, more than 90% of these children still feel pain. Other pain medicines, like acetaminophen (also called Tylenol) and ketorolac (also called Toradol), are available but aren't commonly used because we don't know if they help. The goal of this clinical trial is to test if acetaminophen and/or ketorolac can improve pain control and reduce the need for stronger pain medications (opioids) in these children. To learn more about this, participants will be randomly placed in one of four study treatment groups. This means that a computer will decide by chance which group each participant is in, not the doctors running the study. Each group will receive a combination of intravenous acetaminophen, ketorolac or a harmless substance called a placebo. In this clinical trial, placebos help investigators see if the actual medications (acetaminophen and ketorolac) work better than something that doesn't contain medicine. By comparing participants who get the real medicine with those who get the placebo, investigators can find out if these medications effectively decrease pain.
Primary Outcome
Pain will be assessed using the Face, Legs, Activity, Cry, Consolability (FLACC) score. Coma will be defined using standardized sedation scales. The number of time periods where the participant is both pain-free (FLACC \<4) and coma-free will be recorded.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Ketorolac
Study Locations (15)
Pennsylvania
- Penn State Health/Hershey Medical Center - Hershey
- Children's Hospital of Philadelphia - Philadelphia
- University of Pittsburgh - Pittsburgh
Michigan
- University of Michigan - Ann Arbor
- Children's Hospital of Michigan - Detroit
Ohio
- Rainbow Babies and Children's Hospital - Cleveland
- Nationwide Children's Hospital - Columbus
Arkansas
- Arkansas Children's Hospital - Little Rock
District of Columbia
- Children's National Hospital - Washington D.C.
Minnesota
- University of Minnesota - Minneapolis
North Carolina
- Duke Children's Hospital & Health Center - Durham
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 644 participants |
| Start Date | 2025-12-29 |
| Est. Completion | 2029-08-31 |
| Phase | Phase 3 |
What NCT06994442 shows while recruiting
NCT06994442 is an interventional study that assigns participants to a tested intervention. The registered 644 participants enrollment target is mid-sized for trials with a published cap, above the 551-participant average among 14 other Mechanical Ventilation trials with a reported enrollment target (17% higher).
The record links to 4 conditions, with Mechanical Ventilation appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT06994442 lists 15 locations in 11 states (Pennsylvania, Michigan, Ohio).
Frequently Asked Questions
What is clinical trial NCT06994442 about?
NCT06994442 is a clinical study titled "Optimizing Pain Treatment in Children On Mechanical Ventilation". In this clinical trial, investigators want to learn more about using non-opioid pain medications for children with acute respiratory failure. Right now, doctors give these children opioids to help with pain while they are on the ventilator, but investigators don't know if this is the best way to man...
What is the current status of trial NCT06994442?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 644 participants. The study started on 2025-12-29. Estimated completion is 2029-08-31.
What conditions does trial NCT06994442 study?
This clinical trial studies the following conditions: Mechanical Ventilation, Sedation and Analgesia, Analgesics, Opioid, Pediatric Acute Respiratory Failure.
What interventions are being tested in trial NCT06994442?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Ketorolac (DRUG).
Who is sponsoring clinical trial NCT06994442?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06994442 being conducted?
This trial has 15 study locations across Arkansas, District of Columbia, Michigan, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mechanical Ventilation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06994442's enrollment target sits among peer trials
644 5th of 14 higher than 10 of 14 other Mechanical Ventilation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Mechanical Ventilation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Fentanyl Versus Hydromorphone in Patients on Mechanical Ventilation
RECRUITING · Phase 2
-
RCT: Early Feeding After PEG Placement
RECRUITING · NA
-
Prognostic Estimates Among ICU Clinicians
RECRUITING · NA
-
The ED-AWARENESS-2 Trial
RECRUITING · NA
-
The Effects of Endotracheal Suctioning on Pain and Serum Markers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- NCT04863222 · 646 participants · Phase 4
Clinical and Radiographic Success of MTA vs Biodentine
- NCT05204888 · 642 participants · NA
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI